These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13853338)

  • 1. [Recent data on the pharmacology of chelidonine and sanguinarine].
    KELENTEY B
    Kiserl Orvostud; 1959 Dec; 11():591-8. PubMed ID: 13853338
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effects of sanguinarine on monoamine oxidase activity in mouse brain.
    Lee SS; Kai M; Lee MK
    Phytother Res; 2001 Mar; 15(2):167-9. PubMed ID: 11268121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrotubule properties of benzophenanthridine alkaloids.
    Wolff J; Knipling L
    Biochemistry; 1993 Dec; 32(48):13334-9. PubMed ID: 7902132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the pharmacology of chelidonine and sanguinarine].
    KELENTEY B
    Arzneimittelforschung; 1960 Feb; 10():135-7. PubMed ID: 13853337
    [No Abstract]   [Full Text] [Related]  

  • 5. Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine.
    Kemény-Beke A; Aradi J; Damjanovich J; Beck Z; Facskó A; Berta A; Bodnár A
    Cancer Lett; 2006 Jun; 237(1):67-75. PubMed ID: 16019128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells.
    Kaminskyy V; Lin KW; Filyak Y; Stoika R
    Cell Biol Int; 2008 Feb; 32(2):271-7. PubMed ID: 18029203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of major isoquinoline alkaloids from Chelidonium majus towards telomeric G-quadruplex: A study using a transition-FRET (t-FRET) assay.
    Noureini SK; Esmaeili H; Abachi F; Khiali S; Islam B; Kuta M; Saboury AA; Hoffmann M; Sponer J; Parkinson G; Haider S
    Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):2020-2030. PubMed ID: 28479277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of vibrios to sanguinarine.
    Nandi R; Maiti M; Chaudhuri K; Mahato SB; Bairagi AK
    Experientia; 1983 May; 39(5):524-5. PubMed ID: 6852180
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sanguinarine and ellipticine cytotoxic alkaloids isolated from well-known antitumor plants. Intracellular targets of their action].
    Faddeeva MD; Beliaeva TN
    Tsitologiia; 1997; 39(2-3):181-208. PubMed ID: 9312909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications.
    Walterová D; Ulrichová J; Válka I; Vicar J; Vavrecková C; Táborská E; Harjrader RJ; Meyer DL; Cerná H; Simánek V
    Acta Univ Palacki Olomuc Fac Med; 1995; 139():7-16. PubMed ID: 8686560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human pregnancy plasma diamine oxidase with alkaloids of Argemone mexicana--berberine and sanguinarine.
    Vaidya AB; Rajagopalan TG; Kale AG; Levine RJ
    J Postgrad Med; 1980 Jan; 26(1):28-33. PubMed ID: 6768879
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reaction of cells cultured in vitro to sanguinarine and chelerythrin].
    Půza V; Novák L; Fiala B; Cerná H
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(1):53-9. PubMed ID: 3212396
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of sanguinarine on ventricular refractoriness.
    Whittle JA; Bissett JK; Straub KD; Doherty JE; McConnell JR
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):377-80. PubMed ID: 7414056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of sanguinarine and chelerythrine effects on CYP1A1 expression and activity in human hepatoma cells.
    Zdarilová A; Vrzal R; Rypka M; Ulrichová J; Dvorák Z
    Food Chem Toxicol; 2006 Feb; 44(2):242-9. PubMed ID: 16115718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of sanguinarine in bone resorption models.
    Sakamoto S
    Compend Contin Educ Dent (Lawrenceville); 1986; Suppl 7():S221-3, S226. PubMed ID: 3013500
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sanguinarine--a new antiplaque agent?].
    Bossmann K
    Quintessenz; 1985 Aug; 36(8):1531-5. PubMed ID: 3867930
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of sanguinarine on the GABA synthesizing enzyme glutamate decarboxylase in vitro.
    Netopilova M; Drsata J; Ulrichová J
    Pharmazie; 1996 Aug; 51(8):589-91. PubMed ID: 8794470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of sanguinarine against oral microbial isolates.
    Dzink JL; Socransky SS
    Antimicrob Agents Chemother; 1985 Apr; 27(4):663-5. PubMed ID: 4004199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sanguinarine and hypothalamic glaucoma.
    HAKIM SA
    J All India Ophthalmol Soc; 1962 Dec; 10():83-102. PubMed ID: 13952024
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA-binding affinities and sequence selectivity of quaternary benzophenanthridine alkaloids sanguinarine, chelerythrine, and nitidine.
    Bai LP; Zhao ZZ; Cai Z; Jiang ZH
    Bioorg Med Chem; 2006 Aug; 14(16):5439-45. PubMed ID: 16730995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.